Macrolide-resistant Streptococcus pyogenes: prevalence and treatment strategies

Expert Review of Anti-infective Therapy
Catarina Silva-CostaJose Melo-Cristino

Abstract

Although penicillin remains the first-choice treatment for Streptococcus pyogenes infection, macrolides are important alternatives for allergic patients and lincosamides are recommended together with β-lactams in invasive infections. S. pyogenes may exhibit macrolide resistance because of active efflux (mef genes) or target modification (erm genes), the latter conferring cross resistance to lincosamides and streptogramin B. Worldwide, resistance is restricted to a limited number of genetic lineages, despite resistance genes being encoded on mobile genetic elements. For reasons that are not completely clear, resistance and the associated phenotypes are highly variable across countries. Although resistance remains high in several countries, particularly in Asia, an overall decreasing trend of resistance has been noted in recent years, mostly in Europe. This decrease is not always accompanied by declines in macrolide consumption, suggesting significant roles of other factors in determining the dynamics of macrolide-resistant clones. Continued surveillance is needed to obtain further insights into the forces governing macrolide resistance in S. pyogenes.

References

Jan 1, 1995·The Journal of Antimicrobial Chemotherapy·G J van AsseltJ A van de Klundert
Apr 1, 1995·Antimicrobial Agents and Chemotherapy·B Weisblum
Mar 1, 1995·Antimicrobial Agents and Chemotherapy·B Weisblum
Jan 25, 1996·The New England Journal of Medicine·A L Bisno, D L Stevens
Aug 1, 1997·The Journal of Antimicrobial Chemotherapy·S SriskandanJ Cohen
Apr 12, 2000·The Journal of Antimicrobial Chemotherapy·A Efstratiou
Apr 25, 2000·Annual Review of Medicine·D L Stevens
Jul 25, 2000·Clinical Microbiology Reviews·M W Cunningham
Sep 22, 2001·The Journal of Antimicrobial Chemotherapy·S Douthwaite, W S Champney
Jan 18, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Roland Leclercq
Apr 18, 2002·Antimicrobial Agents and Chemotherapy·Edouard BingenRobert Cohen
Apr 19, 2002·The New England Journal of Medicine·Judith M MartinEllen R Wald
Jun 28, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Alan L BisnoUNKNOWN Infectious Diseases Society of America
Nov 19, 2002·Antimicrobial Agents and Chemotherapy·Eleonora GiovanettiPietro Emanuele Varaldo
Jan 1, 2003·International Journal of Antimicrobial Agents·E PetinakiA N Maniatis
Jan 25, 2003·Antimicrobial Agents and Chemotherapy·Ralf René ReinertAdnan Al-Lahham
Jun 25, 2003·Antimicrobial Agents and Chemotherapy·Kevin C KatzDonald E Low
Oct 22, 2003·The Pediatric Infectious Disease Journal·Michael R Jacobs, Candice E Johnson
Dec 23, 2003·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·UNKNOWN Agence Française de Sécurité Sanitaire des Produits de Santé
Jan 27, 2004·Antimicrobial Agents and Chemotherapy·Michael GreenEllen R Wald
Mar 30, 2004·Antimicrobial Agents and Chemotherapy·Ralf R ReinertAdnan Al-Lahham
May 4, 2004·International Journal of Antimicrobial Agents·Waheeb SakranRaul Colodner
May 6, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Miika BergmanUNKNOWN Finnish Study Group for Antimicrobial Resistance (FiRe Network)
Aug 26, 2004·Antimicrobial Agents and Chemotherapy·Edouard BingenRobert Cohen
Aug 27, 2004·The Journal of Antimicrobial Chemotherapy·Katarzyna SzczypaWaleria Hryniewicz
Dec 4, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Robert R TanzUNKNOWN North American Streptococcal Pharyngitis Surveillance Group
Jan 15, 2005·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Sunjoo Kim, Nam Yong Lee
Apr 26, 2005·International Journal of Antimicrobial Agents·Gabriela RubinsteinGabriel O Gutkind
Apr 28, 2005·Antimicrobial Agents and Chemotherapy·Emilio Pérez-TralleroUNKNOWN Spanish Surveillance Group for Respiratory Pathogens
Apr 28, 2005·Antimicrobial Agents and Chemotherapy·C Silva-CostaUNKNOWN Portuguese Surveillance Group for the Study of Respiratory Pathogens
Apr 28, 2005·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Intetsu KobayashiJingoro Shimada
Jun 21, 2005·Emerging Infectious Diseases·Surbhi Malhotra-KumarHerman Goossens
Aug 5, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Sandra S RichterGary V Doern
Oct 19, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Dennis L StevensUNKNOWN Infectious Diseases Society of America
Oct 29, 2005·The Lancet Infectious Diseases·Jonathan R CarapetisMartin Weber
Apr 28, 2006·Antimicrobial Agents and Chemotherapy·P LittauerG S Simonsen

❮ Previous
Next ❯

Citations

Jul 5, 2015·The Journal of Antimicrobial Chemotherapy·C Silva-CostaUNKNOWN Portuguese Group for the Study of Streptococcal Infections
Apr 28, 2016·The Journal of Antimicrobial Chemotherapy·Athanasios MichosVassiliki P Syriopoulou
Dec 20, 2016·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Sonia KsiaAmel Kechrid
Apr 23, 2017·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·R Creti
Jan 10, 2019·The Journal of Antimicrobial Chemotherapy·Erika A Saliba-GustafssonCecilia Stålsby Lundborg
Aug 17, 2016·Cold Spring Harbor Perspectives in Medicine·Corey FyfeJoyce Sutcliffe
Dec 14, 2019·Acta Microbiologica Et Immunologica Hungarica·Adile MuhtarovaRaina Gergova
Apr 22, 2017·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·B OlzowyUNKNOWN Working Party ‘Antimicrobial Resistance’ of the Paul-Ehrlich-Society for Chemotherapy
Feb 15, 2019·Frontiers in Medicine·Fatma JendoubiJörg Christoph Prinz
Dec 4, 2019·Scientific Reports·A FriãesUNKNOWN Portuguese Group for the Study of Streptococcal Infections
May 31, 2018·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·Elísia LopesUNKNOWN The Portuguese Group For The Study Of Streptococcal Infections
Jan 17, 2021·Scientific Reports·Niluni M WijesundaraH P Vasantha Rupasinghe
Jun 26, 2021·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Katherine FayChris A Van Beneden

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Revista española de quimioterapia : publicación oficial de la Sociedad Española de Quimioterapia
J L BellidoJ A García-Rodríguez
Current Infectious Disease Reports
G G Zhanel, J A Karlowsky
© 2022 Meta ULC. All rights reserved